Assistant Professor
University of Chicago
Ben Derman, MD is an assistant professor of medicine at the University of Chicago specializing in plasma cell disorders. He is interested in integrating measurable residual disease (MRD) diagnostics and immunotherapeutic strategies at the bedside. His research endeavors are focused on MRD in myeloma: novel ways to assess for residual disease, how to use MRD to guide clinical decision making, and how MRD may be used to identify possible cures.
Disclosure information not submitted.
Meet the Experts: MRD in clinical practice
Wednesday, September 17, 2025
12:00 - 12:50 East Coast USA Time